Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colestipol dose-finding study for hyperphosphataemia in haemodialysis patients
ACTRN12614000983606Phase 2Completed
- Sponsor
- Dr Christoper Hood
- Start
- Jul 2012
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of colestipol in hyperphosphatemia and chronic kidney disease (CKD), sponsored by Dr Christoper Hood. Primary endpoints: Change in serum phosphate from end of first washout to end of 8 weeks of colestipol and Change in serum phosphate from end of active treatment to end of second washout. Started Jul 2012; status: completed.
02
Drugs
colestipol
03
Conditions
hyperphosphatemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on ACTRN12614000983606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000983606.